Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting

MISSISSAUGA, ON, June 7, 2016 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.

The detailed results of the votes by proxy are as follows:

Director Nominees

NUMBER OF SHARES

PERCENTAGE OF VOTES CAST

FOR

WITHHELD

FOR

WITHHELD

Daniel Chicoine

3,977,783

46,583

98.84%

1.16%

David A. Copeland

3,916,886

107,480

97.33%

2.67%

Anthony E. Dobranowski

3,917,205

107,161

97.34%

2.66%

John C. London

3,982,114

42,252

98.95%

1.05%

Dr. Jacques Messier

3,985,773

38,593

99.04%

0.96%

Samira Sakhia

3,987,856

36,510

99.09%

0.91%

 

About Nuvo Pharmaceuticals Inc.
Nuvo (TSX:NRI) is a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities.  Nuvo has three commercial products that are available in a number of countries; Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine patch.  Pennsaid 2% is sold in the U.S. by Horizon Pharma plc (NASDAQ: HZNP) and is available for partnering in certain other territories around the world.  Nuvo manufactures Pennsaid for the global market and Pennsaid 2% for the U.S. market at its FDA, Health Canada and EU approved manufacturing facility in Varennes, Québec.  For additional information, please visit www.nuvopharmaceuticals.com.

SOURCE Nuvo Pharmaceuticals Inc.

For further information: PLEASE CONTACT: Investor Relations, Email: ir@nuvopharm.com

RELATED LINKS
http://www.nuvoresearch.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890